Clorox makes branded cleaning and household staples: Clorox bleach and disinfecting wipes, Pine-Sol, Fresh Step and Scoop Away cat litter, Glad bags and wraps, and Hidden Valley dressings. Its moat rests on brand recognition in disinfecting categories where shoppers pay a premium for trust, and a 42.3% gross margin shows that pricing power is still intact. The near-term issue is volume: revenue is shrinking 2.0% year over year, so the question is whether management can stabilize sales and restore margin from the current 12.9% operating level. The stock trades at 14.9x forward earnings against 18.1x trailing, which implies consensus expects earnings to recover, though the 163.8% ROE is inflated by a small equity base and should not be read as a quality signal on its own. At a 40/100 score and no index membership, the name screens as a turnaround candidate rather than a compounder, and it merits a deeper look only if the volume trajectory is the thing to underwrite.
Plain-English pros, cons, and what to watch. Pro feature.
See what each model says, the assumptions behind it, the bad, normal and good cases, and why the fair value changed.
The full quality picture: a reason under every score, how the scores moved, and the conviction breakdown.
The full analyst picture: the price-target distribution against the current price, forward consensus estimates, and how ACCE's own models compare.
Trades are only made public after a delay. We show the delay so you know how old the news is.
Follow the informed money: 13F position changes, insider and Congress trades, and 13D activist filings.
| Date | Type | New | Previous | Price |
|---|---|---|---|---|
| 19 Oct 2026, 18:04 CEST | Rating | Overvalued | first publication | $87.09 |
| 18 Oct 2026, 00:00 CEST | ACCE price target | $90.60 | $93.00 | $87.09 |
| 11 Oct 2026, 00:00 CEST | Fair value | $67.74 | $75.50 | $83.80 |
| 30 Sept 2026, 00:00 CEST | Fair value | $75.50 | $76.27 | $81.42 |
| 26 Sept 2026, 00:00 CEST | Fair value | $76.27 | $74.24 | $81.80 |
| 23 Sept 2026, 00:00 CEST | Fair value | $74.24 | $76.29 | $84.88 |
| 21 Sept 2026, 00:00 CEST | Fair value | $76.29 | $77.38 | $83.10 |
| 14 Sept 2026, 00:00 CEST | Fair value | $77.38 | $78.36 | $87.76 |
| 12 Sept 2026, 00:00 CEST | Fair value | $78.36 | $80.04 | $88.77 |
| 5 Sept 2026, 00:00 CEST | Fair value | $80.04 | $90.30 | $94.27 |
Answered from Clorox Company (The) Common Stock fundamentals + recent valuations. Every number shows its source and date.
| Company | Price | Fair value | vs fair value | P/E | ROE | Quality | Score |
|---|---|---|---|---|---|---|---|
| CLX Clorox Company (The) Common Stock | $86.40 | $67 | 28% above | 18.4x | 163.8% | 64 | 41 |
| MARICO.NS Marico Limited | ₹766.50 | - | - | 52.6x | - | 85 | 57 |
| 8113.T Unicharm Corporation | ¥1019.50 | - | - | 27.3x | 8.3% | 63 | 64 |
| PUIG.MC Puig Brands SA | €19.14 | €16 | 17% above | 18.7x | 15.6% | 72 | 61 |
| 4911.T Shiseido Company, Limited | ¥3709.00 | - | - | - | -3.1% | 52 | 66 |
| GODREJCP.NS Godrej Consumer Products Limited | ₹856.35 | ₹313 | 173% above | 45.8x | 15.1% | 75 | 48 |
| DABUR.NS Dabur India Limited | ₹363.00 | - | - | 32.7x | - | 85 | 51 |
Where CLX ranks against its sector peers on each metric.